AKT1 and esophageal cancer: These data indicated that wortmannin and LY294002 exerted dose-dependent inhibitory effects on the PI3K/AKT pathway and pro-apoptotic proteins, therefore inducing caspase-3-dependent apoptosis in esophageal cancer cells.